RESPONSE TO BROMOCRIPTINE DISTINGUISHES BIPOLAR FROM UNIPOLAR DEPRESSION

[1]  B. Toone,et al.  SWITCH MECHANISM IN AFFECTIVE ILLNESS AND S-ADENOSYLMETHIONINE , 1983, The Lancet.

[2]  J. Baum.  A review of the psychological aspects of rheumatic diseases. , 1982, Seminars in arthritis and rheumatism.

[3]  N. Bouras,et al.  Bromocriptine in depression. , 1982, Current medical research and opinion.

[4]  D. Petrovic,et al.  A comparative, multicenter trial between bromocriptine and amitriptyline in the treatment of endogenous depression. , 1982, Arzneimittel-Forschung.

[5]  T. Silverstone,et al.  Double‐blind comparative clinical trial of pimozide and chlorpromazine in mania , 1981, Acta psychiatrica Scandinavica.

[6]  L. Bertilsson,et al.  Bromocriptine treatment of depressive disorders , 1981, Acta psychiatrica Scandinavica.

[7]  J. Gerlach,et al.  Bromocriptine and imipramine in endogenous depression. A double-blind controlled trial in out-patients. , 1981, Journal of affective disorders.

[8]  J. Lépine,et al.  Bromocriptine in affective disorders. A pilot study. , 1979, Journal of affective disorders.

[9]  M. Casacchia,et al.  Results and possible developments of the clinical use of S-adenosyl-L-methionine (SAMe) in psychiatry. , 1978, Monographien aus dem Gesamtgebiete der Psychiatrie.

[10]  M. Casacchia,et al.  Effect of s-adenosyl-l-methionine (SAMe) upon depressive symptoms. , 1976, Journal of psychiatric research.

[11]  R. Baldessarini.  The basis for amine hypotheses in affective disorders. A critical evaluation. , 1975, Archives of general psychiatry.

[12]  G. Zaphiropoulos,et al.  Depression in rheumatoid disease. , 1974, Annals of the rheumatic diseases.